| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2500032 | P134细胞注射液 | P134 | Biological Products(1) | New Drug Application | 2025-01-10 | Tasly Pharmaceutical Group Co Ltd | view |